非磺酰脲类促胰岛素分泌剂那格列奈的研究进展(4)
[14] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2013年版)[J].中华糖尿病杂志，2014，88(8)：26-89.
[15] Bellomo A，Stefanelu G，Lavola L，et al. Nateglinide provides tighter glycaemic control than glyburide in patients with type 2 diabetes with prevalent postprandiahyperglycaemia [J]. Diabet Med，2011，28(5)：560-566.
[16] Zhou J，Li H，Zhang X，et al. Nateglinide and acarbose are comparably effective reducers of postprandial glycemic excursions in Chinese antihyperglycemic agent-naive subjects with type 2 diabetes [J]. Diabetes Technol Ther ......
您现在查看是摘要页，全文长 3200 字符。
[15] Bellomo A，Stefanelu G，Lavola L，et al. Nateglinide provides tighter glycaemic control than glyburide in patients with type 2 diabetes with prevalent postprandiahyperglycaemia [J]. Diabet Med，2011，28(5)：560-566.
[16] Zhou J，Li H，Zhang X，et al. Nateglinide and acarbose are comparably effective reducers of postprandial glycemic excursions in Chinese antihyperglycemic agent-naive subjects with type 2 diabetes [J]. Diabetes Technol Ther ......
您现在查看是摘要页，全文长 3200 字符。